Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transformation suppressor genes.

M Noda1, H Kitayama, S Kanazawa

  • 1Tsukuba Life Science Center, Institute of Physical and Chemical Research (RIKEN), Ibaraki, Japan.

Princess Takamatsu Symposia
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The frequency of Fabry disease with the E66Q variant in the α-galactosidase A gene in Japanese dialysis patients: a case report and a literature review.

Clinical nephrology·2012
Same author

[Application of the lower partial sternotomy approach to patients who may need tracheostomy in the early period after cardiac surgery].

Kyobu geka. The Japanese journal of thoracic surgery·2011
Same author

Regulation of basophilic and erythroid-differentiation of a human chronic myelogenous leukemia-cell line, ku812f, by interleukin-3 and stem-cell factor.

International journal of oncology·2011
Same author

Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs.

Oncogene·2010
Same author

The membrane-anchored metalloproteinase regulator RECK stabilizes focal adhesions and anterior-posterior polarity in fibroblasts.

Oncogene·2009
Same author

Post-sternotomy mediastinitis following coronary bypass grafting treated by supra-sternal omental transfer without sternal closure.

Journal of medicine·2007
Same journal

Survival after liver transplantation in patients with hepatocellular carcinoma.

Princess Takamatsu symposia·1995
Same journal

Surgical treatment of hepatocellular carcinoma.

Princess Takamatsu symposia·1995
Same journal

Treatment of unresectable hepatocellular carcinoma: targeted therapies using iodized oil.

Princess Takamatsu symposia·1995
Same journal

The present status of treatments for hepatocellular carcinoma.

Princess Takamatsu symposia·1995
Same journal

Prospects for prophylactic and therapeutic hepatitis C virus vaccines.

Princess Takamatsu symposia·1995
Same journal

Association of cytotoxic T lymphocyte (CTL) escape mutations with persistent hepatitis C virus (HCV) infection.

Princess Takamatsu symposia·1995
See all related articles

Researchers identified a novel gene, Krev-1, that suppresses cancer cell malignancy. This gene encodes a protein similar to ras proteins, offering potential new targets for cancer therapy.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Kirsten sarcoma virus transformation of NIH3T3 cells leads to malignant phenotypes.
  • Identifying genes that reverse these malignant traits is crucial for understanding cancer progression.

Purpose of the Study:

  • To isolate and characterize genes capable of suppressing malignancy in transformed cells.
  • To investigate the functional properties of a newly identified gene, Krev-1.

Main Methods:

  • Transfection of NIH3T3 cells with a normal human fibroblast cDNA expression library.
  • Isolation and characterization of flat revertant cell lines with reduced malignancy.
  • Recovery and analysis of the Krev-1 cDNA clone and its encoded protein.

Related Experiment Videos

Main Results:

  • A 1.8 kb cDNA clone, Krev-1, was isolated and demonstrated revertant-inducing activity.
  • Krev-1 encodes a protein (21 kDa) structurally similar to ras proteins, particularly in key functional domains.
  • Specific point mutations in Krev-1 potentiated its transformation suppressor activity, while others reduced it.

Conclusions:

  • Krev-1 acts as a suppressor of Kirsten sarcoma virus-induced cell transformation and malignancy.
  • The Krev-1 protein's functional domains are critical for its tumor suppressor activity.
  • Krev-1 represents a potential therapeutic target for modulating ras-related cancers.